(amounts in thousands)
Sep. 30, Dec. 31,
Cash and cash equivalents $2,785 $1,990
Other current assets 578 1,041
Total current assets 3,363 3,031
Property, net 127 75
Other assets 368 140
Total assets $3,858 $3,246
Liabilities and stockholders' equity
Current liabilities $516 $598
Stockholders' equity 3,342 2,648
Total liabilities and stockholders' equity $3,858 $3,246
Shares Outstanding 743,415 731,628
About GeoVax Labs, Inc.
GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's HIV/AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax HIV/AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax HIV/AIDS vaccines also may be effective as therapeutics (treatment of people already infected with AIDS virus). Studies evaluating these vaccines in HIV/AIDS infected individuals are in the planning stage.
GeoVax's core HIV/AIDS vaccine technologies were developed through a
collaboration of colleagu
|SOURCE GeoVax Labs, Inc.|
Copyright©2008 PR Newswire.
All rights reserved